VHM-314-CHG-001 Date: [Current Date] Author: [Your Name/Role] Status: Final
Unlike classic psychedelics (such as psilocybin or LSD) that cause profound hallucinations, Vhm-314 was designed for "sub-psychedelic" dosing. The goal was to promote neuroplasticity, reduce anxiety, and enhance cognitive flexibility without perceptual alterations. This placed it in the emerging class of drugs often called "psychoplastogens" or non-hallucinogenic serotonergics. Vhm-314 Change Name
Warranty: Modifying the firmware or soldering onto the board will void any return policy from the seller. Warranty: Modifying the firmware or soldering onto the
If you participated in an early-phase trial of Vhm-314, your consent forms and follow-up records will eventually be migrated to the new name. Always provide the generic chemical name (e.g., IUPAC name) alongside the brand name to avoid confusion. Do not attempt to source "Vhm-314" online—name changes often coincide with regulatory crackdowns on grey-market sales. Do not attempt to source "Vhm-314" online—name changes